当前位置: X-MOL 学术Clin. Hemorheol. Microcirc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early evaluation of organ failure using MELD-XI in critically ill elderly COVID-19 patients
Clinical Hemorheology and Microcirculation ( IF 2.1 ) Pub Date : 2021-08-28 , DOI: 10.3233/ch-219202
Raphael Romano Bruno 1 , Bernhard Wernly 2 , Johanna Hornemann 1 , Hans Flaatten 3 , Jesper FjØlner 4 , Antonio Artigas 5 , Bernardo Bollen Pinto 6 , Joerg C Schefold 7 , Georg Wolff 1 , Philipp Heinrich Baldia 1 , Stephan Binneboessel 1 , Malte Kelm 1 , Michael Beil 8 , Sigal Sviri 8 , Peter Vernon van Heerden 9 , Wojciech Szczeklik 10 , Muhammed Elhadi 11 , Michael Joannidis 12 , Sandra Oeyen 13 , Eumorfia Kondili 14 , Jakob Wollborn 15 , Brian Marsh 16 , Finn H Andersen 17, 18 , Rui Moreno 19 , Susannah Leaver 20 , Ariane Boumendil 21, 22 , Dylan W De Lange 23 , Bertrand Guidet 21, 22 , Christian Jung 1 ,
Affiliation  

Abstract

PURPOSE

Critically ill elderly patients who suffer from Sars-CoV-2 disease are at high risk for organ failure. The modified MELD-XI score has not been evaluated for outcome prediction in these most vulnerable patients.

METHODS

The Corona Virus disease (COVID19) in Very Elderly Intensive Care Patients study (COVIP, NCT04321265) prospectively recruited patients on intensive care units (ICU), who were = 70 years. Data were collected from March 2020 to February 2021. The MELD-XI score was calculated using the highest serum bilirubin and creatinine on ICU admission. Univariate and multivariable logistic regression analyses were performed to assess associations between the MELD-XI score and mortality. The primary outcome was 30-day-mortality, the secondary outcomes were ICU- and 3-month-mortality.

RESULTS

In total, data from 2,993 patients were analyzed. Most patients had a MELD-XI <12 on admission (76%). The patients with MELD-XI = 12 had a significantly higher 30-day-, ICU- and 3-month-mortality (44%vs 64%, and 42%vs. 59%, and 57%vs. 76%, p < 0.001). After adjustment for multiple confounders, MELD-XI = 12 remained significantly associated with 30-day- (aOR 1.572, CI 1.268–1.949, p < 0.001), ICU-, and 3-month-mortality.

CONCLUSION

In critically ill elderly intensive care patients with COVID-19, the MELD-XI score constitutes a valuable tool for an early outcome prediction.



中文翻译:

使用 MELD-XI 在危重老年 COVID-19 患者中早期评估器官衰竭

摘要

目的

患有 Sars-CoV-2 疾病的危重老年患者处于器官衰竭的高风险中。尚未对修改后的 MELD-XI 评分对这些最脆弱患者的结果预测进行评估。

方法

高龄重症监护患者研究 (COVIP, NCT04321265) 中的冠状病毒病 (COVID19) 前瞻性地招募了重症监护病房 (ICU) 的患者,这些患者的年龄为 70 岁。数据收集时间为 2020 年 3 月至 2021 年 2 月。 MELD-XI 评分使用 ICU 入住时的最高血清胆红素和肌酐计算。进行单变量和多变量逻辑回归分析以评估 MELD-XI 评分与死亡率之间的关联。主要结果是 30 天死亡率,次要结果是 ICU 和 3 个月死亡率。

结果

总共分析了 2,993 名患者的数据。大多数患者入院时 MELD-XI <12 (76%)。MELD-XI = 12 的患者具有显着更高的 30 天、ICU 和 3 个月死亡率(44% 对 64%、42% 对 59%、57% 对 76%,p < 0.001)。调整多个混杂因素后,MELD-XI = 12 仍然与 30 天死亡率(aOR 1.572,CI 1.268–1.949,p < 0.001)、ICU 死亡率和 3 个月死亡率显着相关。

结论

在患有 COVID-19 的危重老年重症监护患者中,MELD-XI 评分构成了早期结果预测的宝贵工具。

更新日期:2021-09-01
down
wechat
bug